Rebetol

Active Ingredient(s): Ribavirin
FDA Approved: * June 3, 1998
Pharm Company: * SCHERING PLOUGH RES
Category: Antiviral

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Rebetol Overview

The most successful ribavirin derivative to date is the 3-carboxamidine derivative of the parent 3-carboxamide, first reported in 1973 by J. T. Witkowski et al.,[43] and now called taribavirin (former names "viramidine" and "ribamidine"). This drug shows a similar spectrum of antiviral activity to ribavirin, which is not surprising as it is now known to be a pro-drug for ribavirin. Taribavirin, however, has useful properties of less erythrocyte-trapping and better liver-target...

Read more Rebetol Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ribavirin

Recent Rebetol Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Ribavirin
  • Capsule: 200mg
  • For Solution: 6gm/vial
  • Powder for Reconstitution: 6g
  • Solution: 40mg/ml
  • Tablet: 200mg, 400mg, 500mg, 600mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Rebetol: (4 results)

Sorted by National Drug Code
  • 0085-1194 Rebetol 200 mg Oral Capsule by Merck Sharp & Dohme Corp.
  • 0085-1318 Rebetol 40 mg/ml Oral Liquid by Merck Sharp & Dohme Corp.
  • 0085-1351 Rebetol 200 mg Oral Capsule by Merck Sharp & Dohme Corp.
  • 0085-1385 Rebetol 200 mg Oral Capsule by Merck Sharp & Dohme Corp.

Other drugs which contain Ribavirin or a similar ingredient: (10 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 8 May 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA